Audentes Therapeutics, Inc. logo

Audentes Therapeutics, Inc.

Audentes is engaged in the development and commercialization of gene therapy products for patients with muscle diseases.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”BOLD” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.audentestx.com
Founded2013
Disease Focus
Development Stage
STOCK CODENASDAQ: BOLD
Address
600 California Street, 17th Floor CA 94108
San Francisco
United States
Email
Contact Number
+1 415 818 1001

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/audentes-therapeutics” connections=”true” suffix=””]